DCE-MRI for Early Prediction of Response in Hepatocellular Carcinoma after TACE and Sorafenib Therapy: A Pilot Study

OBJECTIVE: Dynamic contrast-enhanced MRI (DCE-MRI) can measure the changes in tumor blood flow, vascular permeability and interstitial and intravascular volume. The objective was to evaluate the efficacy of DCE-MRI in prediction of Barcelona Clinic Liver Cancer (BCLC) staging B or C hepatocellular c...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Kazuhiro, Ledsam, Joseph, Sugimoto, Katsutoshi, Sourbron, Steven, Araki, Yoichi, Tokuuye, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032464/
https://www.ncbi.nlm.nih.gov/pubmed/30039052
http://dx.doi.org/10.5334/jbsr.1278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032464/
https://www.ncbi.nlm.nih.gov/pubmed/30039052
http://dx.doi.org/10.5334/jbsr.1278

Ejemplares similares